FindMyKOL

Lara Kovell, MD

Enriched profile

Associate Professor · UMass Chan Medical School

ORCID↗NPI↗
✓ Itemized profile
Region🇺🇸 Worcester, MA · Northeast · United StatesSpecialtyCardiovascular DiseaseFocusBlood Pressure and Hypertension Studies+4
Active KOLFindMyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2024–2024NIH funding2024–2026

Lara Kovell is Associate Professor at UMass Chan Medical School. OpenAlex indexes 148 publications with 1,684 citations (h-index 21); ClinicalTrials.gov lists 1 registered study with this person as an investigator.

Data verified 3 Nov 2026

Overview

Updated 3 Nov 2026

Lara Kovell is Associate Professor at UMass Chan Medical School. The public record shows 148 publications with 1,684 citations (h-index 21), centered on Blood Pressure and Hypertension Studies, Pregnancy and preeclampsia studies, Cardiovascular Function and Risk Factors. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 1 companies, 1 NIH-funded awards (2024–2026).

  • Most recent indexed publication: 2026 · Circulation. Population health and outcomes
  • Top research focus: Blood Pressure and Hypertension Studies
  • 1 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 1 companies

Generated from the cited public record · current as of 3 Nov 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Hypertension1 trialHypertension, Pregnancy-Induced1 trialCystic FibrosisType 2 DiabetesLung Cancer (NSCLC/SCLC)COVID-19COPDHeart FailureCoronary Artery Disease / ACSAtrial FibrillationGoutNeuro-Oncology / GliomaPulmonary HypertensionChronic Kidney DiseaseStrokeHIVDyslipidemia / Lipid Disorders

Research focus

OpenAlex concept fingerprint
Blood Pressure and Hypertension StudiesPregnancy and preeclampsia studiesCardiovascular Function and Risk FactorsMobile Health and mHealth ApplicationsCardiovascular Issues in Pregnancy

Works with

trial sponsors and companies reporting payments
Novo Nordisk IncClinical trials—Industry payments1University of Massachusetts, WorcesterClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
148publications

Publications indexed by OpenAlex, matched via ORCID. 12 in PubMed. Counts exclude supporting files.

1,684citations

Citations across these publications.

21h-index

H-index from these publications. i10-index 35.

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials ↓
1companies · 2024–2024

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 2024–2026

Federally funded research awards.

View funding ↓

Public positions

sourced statements on record
  • Site principal investigator

    RESILIENT trial

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →umassmed.edu ↗

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 3 Nov 2026

Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:

Industry payments

Updated 3 Nov 2026

1 company reported payments to CMS in program years 2024–2024. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    93.3%
    Beta blocker27.9%
    Metoprolol Succinate61%Carvedilol39%
    Part D≥23 patients
    Statin26.1%
    Atorvastatin Calcium54%Rosuvastatin Calcium46%
    Part D≥22 patients

    + 6 more classes in this area

  • Blood & clotting

    6.7%
    Factor Xa inhibitor6.7%
    Eliquis100%
    Part D<11 patients
Where care is delivered (Part B)89.6% facility · 10.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 3 Nov 2026

1 NIH research award on record, funded 2024–2026 per NIH RePORTER. The latest:

All 4 award records: search, sort and filter.Explore →

Publications

Updated 3 Nov 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 12 publications: search, sort and filter.Explore →

Most-cited works

by citation count (OpenAlex)
All 148 cited works: search, sort and filter.Explore →

Network

Updated 3 Nov 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Stephen Paul Juraschek42Gianna Wilkie28Colleen M. Harrington17Mawulorm Denu16David D. McManus15Tiffany A. Moore Simas14Lawrence J. Appel14Katherine Anais Sadaniantz14Gerard P. Aurigemma13Kenneth Jay Mukamal12Antoinette Schoenthaler11John A. Dodson11Samrachana Adhikari11Sravya B. Shankara11Sharina D. Person10Stephenie C. Lemon10Edgar R. Miller9Didem Ayturk8Jonathan H. Whiteson8Robert H. Christenson8Heather Rebuck8Edgar R. Miller8Greg Sweeney8Barbara J. George8Timothy B. Plante7Ekaterina Skaritanov7Kevin Phillip Marzo7Diana Sibai7Angela Essa7Claire V. Meyerovitz7Benjamin Maxner7Sanjna Iyengar6Frank M. Sacks6Alex R. Chang6Erin D. Michos6Stephanie Pena6Andrea B. Troxel5

Online presence

Updated 3 Nov 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/lara-kovell-md

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • LinkedIn

    linkedin.com/in/lara-kovell-7aa2a6395

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • ResearchGate

    researchgate.net/profile/Lara-Kovell

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • Google Scholar

    scholar.google.com/citations

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →scholar.google.com ↗

Mentions by others

where others cite or feature them
  • Other

    profiles.umassmed.edu/display/16504483

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.umassmed.edu ↗
  • Other

    providers.ummhealth.org/LaraKovellMD/056008

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →providers.ummhealth.org ↗
  • Other

    umassmed.edu/medicine/research/researcher-spotlights/february-2024

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →umassmed.edu ↗
  • X / Twitter

    @lckovell (X account)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 3 Nov 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.